Clopidogrel-Hydrogen-Sulfate shortage status
No active shortage currently reported by the regulators Mederti tracks — 2 anticipated notices on file.
Last updated 30 Oct 2026 · sourced from official medicines regulators
- Generic name (INN)
- Clopidogrel-Hydrogen-Sulfate
- Brand names
- PIAX clopidogrel
- ATC code
- B01AC04
- Class
- Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
Recent shortage history
- Australia: resolved 8 May 2026 (began 21 Jul 2025)
- Australia: resolved 8 May 2026 (began 14 Jul 2025)
- Australia: resolved 15 Jan 2026 (began 10 Jul 2025)
- Australia: resolved 2 Apr 2026 (began 5 Mar 2025)
Frequently asked questions
Is Clopidogrel-Hydrogen-Sulfate currently in shortage?
No active shortage of Clopidogrel-Hydrogen-Sulfate is currently reported by any of the national medicines regulators Mederti tracks. Shortages can emerge quickly — this page updates daily from official sources.
Where does this Clopidogrel-Hydrogen-Sulfate shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Related medicines
Acenocoumarol · Heparin (Heparin Sodium In 0.9% Sodium Chloride Injection) · Heparin Sodium Injection Usp · Heparin Sodium · Heparin-Sodium · Heparin Sodium Inj. Usp
Get alerted when Clopidogrel-Hydrogen-Sulfate status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.